Sangamo Therapeutics Inc (SGMO)

May 15, 2025

Sangamo Biosciences’ Earnings Call: Progress Amid Challenges - TipRanks

May 15, 2025

May 14, 2025

Sangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025

May 14, 2025

Barclays Updates Price Target for Sangamo Therapeutics (SGMO) | - GuruFocus

May 14, 2025

May 14, 2025

Sangamo (SGMO) Price Target Reduced by Barclays | SGMO Stock New - GuruFocus

May 14, 2025

May 13, 2025

Sangamo Biosciences Announces $23 Million Share Offering - TipRanks

May 13, 2025

May 13, 2025

Sangamo Therapeutics (SGMO) Projects 2025 Operating Expenses Ami - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics Inc (SGMO) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo Finance

May 13, 2025

May 13, 2025

Sangamo Therapeutics Inc (SGMO) Q1 2025 Earnings Call Highlights - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics prices $23M securities offering - MSN

May 13, 2025

May 13, 2025

Market Setbacks: Major Stocks Face Financial Hurdles - Finimize

May 13, 2025

May 13, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 13, 2025

Sangamo Therapeutics (SGMO) Announces $23M Capital Raise - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics (SGMO) Reports First Quarter Revenue Below - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics (SGMO) Q1 Earnings Miss Expectations - GuruFocus

May 13, 2025

May 13, 2025

Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day - BioSpace

May 13, 2025

May 13, 2025

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering - BioSpace

May 13, 2025

May 13, 2025

Sangamo Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 13, 2025

May 12, 2025

Sangamo Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025

May 12, 2025

Transcript : Sangamo Therapeutics, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com

May 12, 2025

May 12, 2025

Earnings call transcript: Sangamo Therapeutics faces stock drop after Q1 2025 call - Investing.com Nigeria

May 12, 2025

May 12, 2025

Sangamo Therapeutics Reports Recent Business Highlights and Firs - GuruFocus

May 12, 2025

May 12, 2025

Sangamo Therapeutics (SGMO) Reports First Quarter Revenue Below Expectations | SGMO Stock News - GuruFocus

May 12, 2025

May 12, 2025

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwri - GuruFocus

May 12, 2025

May 12, 2025

Sangamo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Sangamo Therapeutics, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:SGMO) - Seeking Alpha

May 12, 2025

May 12, 2025

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results - BioSpace

May 12, 2025

May 12, 2025

Sangamo: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025

May 12, 2025

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call - Zenopa

May 12, 2025

May 12, 2025

Sangamo Therapeutics (SGMO) Anticipates Q1 Earnings Release - GuruFocus

May 12, 2025

May 08, 2025

Sangamo hits milestone toward accelerated approval for ST-920 - Fabry Disease News

May 08, 2025

May 07, 2025

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease - BioSpace

May 07, 2025

May 06, 2025

Sangamo Biosciences Receives Nasdaq Deficiency Notice - TipRanks

May 06, 2025

May 06, 2025

Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) - Zenopa

May 06, 2025

May 06, 2025

Sangamo advances gene therapy for Fabry disease By Investing.com - Investing.com India

May 06, 2025

May 06, 2025

Sangamo Therapeutics Announces Important Derisking Milestones in - GuruFocus

May 06, 2025

May 06, 2025

Sangamo advances gene therapy for Fabry disease - Investing.com

May 06, 2025

May 06, 2025

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease | SGMO Stock News - GuruFocus

May 06, 2025

May 05, 2025

Sangamo Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

May 05, 2025

May 01, 2025

Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 01, 2025

Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

Fabry Disease Market: Epidemiology, Drugs, Companies, DelveInsight | Amicus Therapeutics, CHIESI Farmaceutici and Protalix Biotherapeutics, Sanofi (Genzyme), Takeda Pharmaceuticals, Sangamo Therapeuti - The Globe and Mail

Apr 29, 2025

Apr 28, 2025

Sangamo Therapeutics to Present Neurology Pipeline Advances at t - GuruFocus

Apr 28, 2025

Apr 26, 2025

Sangamo Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Apr 26, 2025

Apr 26, 2025

Sangamo Therapeutics, Inc. (SGMO) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire

Apr 26, 2025